Preventing Hospital-Associated Venous Thromboembolism

References

Preface

  1. U.S. Department of Health and Human Services. Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. 2008. Available at: http://www.ncbi.nlm.nih.gov/books/NBK44178/. Accessed May 11, 2016.
  2. Deitzelzweig SB, Johnson BH, Lin J, et al. Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections. Am J Hemat 2011;86(2):217-20.
  3. Heit JA, Melton LJ, Lohse CM, et al. Incidence of venous thromboembolism in hospitalized patients versus community residents. Mayo Clin Proc 2001;76:1102-10.
  4. Heit JA , Silverstein MD , Mohr DN , et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160(6):809-15.
  5. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2002;162:1245-8.
  6. Tapson VF, Hyers TM, Waldo AL, et al. Antithrombotic therapy practices in U.S. hospitals in an era of practice guidelines. Arch Intern Med 2005;165:1458-64.
  7. Clagett GP, Anderson FA Jr, Heit J,et al. Prevention of venous thromboembolism. Chest 1995;108:312S-334S.
  8. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;Feb;141(2 Suppl):e419S-94S.
  9. White RH. The epidemiology of venous thromboembolism. Circulation 2003;Jun 17;107(23 Suppl 1):I4-8.
  10. EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010 Dec 23;363(26):2499-510.
  11. EINSTEIN-PE Investigators, Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012 Apr 5;366(14):1287-97.
  12. Levi M, Hovingh GK, Cannegieter SC, et al. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood 2008 May 1;111(9):4471-6.
  13. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007 Feb;92(2):199-205.
  14. Kahn SR. How I treat postthrombotic syndrome. Blood 2009 Nov 19;114(21):4624-31.
  15. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004 May 27;350(22):2257-64.
  16. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. Chest 2008 Jun;133:6 suppl 381S-453S.
  17. Shojania KG, McDonald KM, Wachter RM, et al. Closing The quality gap: a critical analysis of quality improvement strategies. Volume 1—Series Overview and Methodology. Technical Review 9 (Contract No. 290-02-0017 to the Stanford University–University of California, San Francisco, Evidence-based Practices Center). Rockville, MD: Agency for Healthcare Research and Quality. August 2004. AHRQ Publication No. 04-0051-1. /research/findings/evidence-based-reports/qgap1tp.html. Accessed May 11,  2016.
  18. Qaseem A, Chou R, Humphrey LL, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011 Nov 1;155(9):625-32.
  19. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Chest 2012;141:2 suppl e195S-e226S.
  20. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Chest 2012 Feb;141:2 suppl e227S-e277S.
  21. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Chest 2012 Feb;141:2 suppl e278S-e325S.
  22. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2013;31(17):2189-2204.
  23. Committee on Practice Bulletins–Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007;110:429-40.
  24. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 Feb;141(2 Suppl):7S-47S.
  25. Monreal M, Kakkar A, Caprini J, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004;2:1892-8.
  26. Tapson V, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936-45.
  27. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371(9610):387-94.
  28. Bergmann JF, Cohen AT, Tapson VF, et al.;ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost 2010 Apr;103(4):736-48. Epub 2010 Feb 2.
  29. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145-55. Epub 2006 Mar 3.
  30. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
  31. National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures. Available at http://www.qualityforum.org/Publications/2006/12/National_Voluntary_Consensus_Standards_for_Prevention_and_Care_of_Venous_Thromboembolism__Policy,_Preferred_Practices,_and_Initial_Performance_Measures.aspx. Accessed June 14, 2012.
  32. The Joint Commission. Performance Measurement Initiatives. Available at https://www.jointcommission.org/performance_measurement.aspx. Accessed May 11,  2016.
  33. Medicare Quality Improvement Committee. SCIP Project Information. Available from AHRQ National Quality Measures Clearinghouse: http://www.qualitymeasures.ahrq.gov/content.aspx?id=35538&search=scip. Accessed March 2013.
  34. Centers for Medicare & Medicaid Services, Center for Medicare and Medicaid Innovation. Partnership for Patients. http://www.innovations.cms.gov/initiatives/Partnership-for-Patients/index.html. Accessed December 10, 2012.
  35. Shekelle PG, Pronovost PJ, Wachter RM, et al. The top patient safety strategies that can be encouraged for adoption now. Ann Int Med 2013;158:365-8.
  36. American Public Health Association. Deep-vein thrombosis: advancing awareness to protect patient lives. White Paper. Public Health Leadership Conference on Deep-Vein Thrombosis. Washington, DC; February 26, 2003. http://www.leepbook.com/eventdownloads/4168_APHAWhitePaperonDeep-VeinThrombosis.pdf. Accessed May 11,  2016.
  37. Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. Prepared by the Society of Hospital Medicine. Rockville, MD: Agency for Healthcare Research and Quality. August 2008. AHRQ Publication No. 08-0075.
  38. Maynard G, Stein J. Implementation guide-optimize prevention of venous thromboembolism at your medical center. Society of Hospital Medicine Web site, VTE Quality Improvement Resource Room. http://www.hospitalmedicine.org/Web/Quality_Innovation/Implementation_Toolkits/Venous_Thromboembolism/Web/Quality___Innovation/Implementation_Toolkit/Venous/Overview.aspx. Accessed May 11,  2016.
  39. Maynard G, Morris T, Jenkins I, et al. Optimizing prevention of hospital acquired venous thromboembolism: prospective validation of a VTE risk assessment model. J Hosp Med 2010 Jan:5(1):10-18.
  40. Jenkins I, Helmons P, Martin-Armstrong LM, et al. Effect of increased venous thromboembolism prophylaxis on the incidence of heparin-induced thrombocytopenia. J Hosp Med 2010;5:S38.
  41. Stein J, Chernetsky Tejedor S, Shabbir H, et al. Situational awareness improves prevalence of VTE Prophylaxis on multiple nursing units. J Hosp Med 2008;3(S1): 41.
  42. Maynard G, Stein J. Designing and implementing effective VTE prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  43. Maynard GA, Budnitz TL, Nickel WK, et al. Mentored implementation: building leaders and achieving results through a collaborative improvement model. 2011 John M. Eisenberg Patient Safety and Quality Award, National Level. Jt Comm J Qual Patient Saf 2012:38(7):301-10.
  44. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005 Mar 10;352(10):969-77.
  45. Cohn S, Adekile A, Mahabir V. Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention. J Hosp Med 2006 Nov;1(6):331-8.
  46. Bullock-Palmer RP, Weiss S, Hyman C. Innovative approaches to increase deep vein thrombosis prophylaxis rate resulting in a decrease in hospital-acquired deep vein thrombosis at a tertiary-care teaching hospital. J Hosp Med 2008;3(2):148-55.
  47. O'Connor C, Adhikari N, DeCaire K, et al. Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes. J Hosp Med 2009;4(2):81-89.
  48. Maynard G. Medical admission order sets to improve deep vein thrombosis prevention: a model for others or a prescription for mediocrity? J Hosp Med 2009;4(2):77-80.
  49. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241:397-415.
  50. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995;153:1423-31.
  51. Kakkar AK, Davidson BL, Haas SK. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004;2:221-7.
  52. Levi D, Kupfter Y, Seneviratne C, et al. Computerized order entry sets and intensive education improve the rate of prophylaxis for deep vein thrombophlebitis. Chest 1998;114S:280S.
  53. Dobesh PP, Stacy ZA. Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients. J Manag Care Pharm 2005;11:755-62.
  54. Timmons S, O'Callaghan C, O'Connor M, et al. Audit guided action can improve the compliance with thromboembolic prophylaxis prescribing to hospitalized, acutely ill older adults. J Thromb Haemost 2005;3:2112-3.
  55. Mosen D, Elliott CG, Egger MJ, et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 2004;125:1635-41.
  56. Durieux P, Nizard R, Ravaud P, et al. A clinical decision support system for prevention of venous thromboembolism. JAMA 2000;283:2816-21.
  57. Dexter PR, Perkins S, Overhage JM, et al. A computerized reminder system to increase the use of preventive care for hospitalized patients. N Engl J Med 2001;345:965-70.
  58. Streiff MB, Carolan HT, Hobson DB, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;Jun 19;344:e3935.
  59. Gawande, A. The checklist manifesto: how to get things right. New York, NY: Metropolitan Books; 2009.
  60. Baroletti S, Munz K, Sonis J, et al. Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis 2008;25:146-50.
  61. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009;119:2196-2201.
  62. University HealthSystem Consortium. DVT/PE 2007 Knowledge Transfer Meeting (proceedings of November 30, 2007 meeting). 
  63. Arya R, Hunt B, eds. Venous thromboembolism prevention: a guide for delivering the CQUIN goal. London, UK: King's Thrombosis Centre; 2010.
  64. Kahn SR, Morrison DR, Cohen JM, et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism (Review). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008201.
  65. Lederle FA, Zylla D, MacDonald R, et al. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2011;Nov 1;155(9):602-15.

Chapter 1

  1. Langley GJ, Nolan KM, Nolan TW, et al. The improvement guide. San Francisco: Jossey-Bass; 1996.
  2. Kilo CM. A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement's Breakthrough Series. Qual Manage Health Care 1998;6(4):1-13.
  3. Berwick DM, Nolan TW. Physicians as leaders in improving healthcare: a new series in Annals of Internal Medicine. Ann Intern Med 1998;128:289-92.
  4. Powell AE, Rushmer RK, Davies HTO. A systematic narrative review of quality improvement models in healthcare. Edinburgh, Scotland: NHS Quality Improvement; February 2009. http://www.healthcareimprovementscotland.org/previous_resources/hta_report/a_systematic_narrative_review.aspx. Accessed May 11,  2016.
  5. Institute for Healthcare Improvement. Innovation Series 2005: Going lean in healthcare. Cambridge, MA, Institute for Healthcare Improvement; 2005.
  6. Varkey P, Reller K, Resar RK. Basics of quality improvement in healthcare. Mayo Clin Proc 2007;82(6):735-9.
  7. Antony J, Downey-Ennis K, Antony F, et al. Can Six Sigma be the "cure" for our "ailing" NHS?" Leadership Health Serv 2007;20(4):242-53.
  8. Agency for Healthcare Research and Quality. TeamSTEPPS®. http://www.ahrq.gov/teamstepps.Accessed September 29, 2015.
  9. Pronovost P, Berenholz S, Needham D. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337.
  10. Maynard G, Lee J, Phillips GW, et al. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 2009 Jan;4(1):3-15.
  11. Lee J, Clay B, Ziband Z, et al. Indication based ordering: a new paradigm for glycemic control in hospitalized inpatients. J Diabetes Science Tech 2008;2(3):349-56.
  12. Maynard G, Morris T, Jenkins I, et al. Optimizing prevention of hospital acquired venous thromboembolism: prospective validation of a VTE risk assessment model. J Hosp Med 2010 Jan:5(1):10-18.
  13. Ramos P, Childers D, Maynard G, et al. Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach. J Hosp Med 2010:5(8):446-51.
  14. Maynard G, Jenkins I, Clay B, et al. Optimizing inpatient anticoagulation: strategies for quality improvement. In: Fang MC, ed. Inpatient Anticoagulation. Hoboken, NJ: John Wiley and Sons; 2011. p 377-414.
  15. Maynard G, Humber D, Jenkins I. Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism. Am J Hosp Pharm 2014;71(4):305-10.
  16. Williams MV, Budnitz T, Greenwald JL, et al. Project BOOST implementation guide - better outcomes for older adults via safe transitions. Philadelphia: Society of Hospital Medicine; 2009.
  17. Maynard GA, Budnitz TL, Nickel WK, et al. Mentored Implementation: building leaders and achieving results through a collaborative improvement model. 2011 John M. Eisenberg Patient Safety and Quality Award, National Level. Jt Comm J Qual Patient Saf 2012:38(7):301-10.
  18. Hansen LO, Greenwald JL, Budnitz T, et al. Project BOOST: effectiveness of a multihospital effort to reduce rehospitalization. J Hosp Med 2013;8(8):421-7.
  19. Rogers K, Childers D, Messler J, et al. glycemic control mentored implementation: creating a national network of shared information. Jt Comm J Qual Patient Saf 2014;40(3):111-8.
  20. Maynard G, Stein J. Designing and implementing effective VTE prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  21. Kahn SR, Morrison DR, Cohen JM, et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism (Review). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008201.
  22. Streiff BM, Carolan HT, Hobson DV, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.
  23. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241(3):397-415.
  24. Mahan CE, Spyropoulos AC. Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract 2010;38(1):97-108.
  25. Michota F. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med 2007;22(12):1762-70.
  26. Dobesh PP. Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy 2009;29(8):943-53.
  27. Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. Prepared by the Society of Hospital Medicine. Rockville, MD: Agency for Healthcare Research and Quality; August 2008. AHRQ Publication No. 08-0075.
  28. Maynard G, Stein J. Implementation Guide—Optimize Prevention of Venous Thromboembolism at Your Medical Center. Society of Hospital Medicine Web site, VTE Quality Improvement Resource Room. http://www.hospitalmedicine.org/Web/Quality_Innovation/Implementation_Toolkits/Venous_Thromboembolism/Web/Quality___Innovation/Implementation_Toolkit/Venous/Overview.aspx. Accessed May 11,  2016.

Chapter 2

  1. Maynard G, Stein J. Designing and implementing effective vte prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  2. Kahn SR, Morrison DR, Cohen JM, et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism (Review). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008201.
  3. Streiff BM, Carolan HT, Hobson DV, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.

Chapter 3

  1. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;Feb;141(2 suppl):7S-47S.
  2. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Chest 2012 141(2 suppl):e195S-e226S.
  3. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Chest 2012 Feb;141(2 suppl):e227S-e277S.
  4. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Chest 2012 Feb;141(2 suppl):e278S-e325S.
  5. Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed. Chest 2012 Feb;141(2 suppl):e691S-e736S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278054/. Accessed May 11, 2016.
  6. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism. Chest 2008 Jun;133(6 suppl):381S-453S.
  7. Qaseem A, Chou R, Humphrey LL, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011 Nov 1;155(9):625-32.
  8. Lederle FA, Zylla D, MacDonald R, et al. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2011 Nov 1;155(9):602-15.
  9. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2013;31(17):2189-2204.
  10. Jacobs JJ, Mont MA, Bozic KJ, et al. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. Evidence-based guideline and evidence report from the American Academy of Orthopaedic Surgeons. 2d ed. 2011. http://www.aaos.org/research/guidelines/VTE/VTE_full_guideline.pdf. Accessed May 11, 2016
  11. Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007;110:429-40.
  12. Committee on Practice Bulletins—Obstetrician-Gynecologists. Thromboembolism in pregnancy. Practice Bulletin 2011;118(3):718-29. http://www.acog.org/Resources_And_Publications/Practice_Bulletins/Committee_on_Practice_Bulletins_Obstetrics/Thromboembolism_in_Pregnancy. Accessed May 11, 2016
  13. NHS National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE Clinical Guideline 92. 2010. www.nice.org.uk/guidance/CG92. Accessed April 18, 2013.
  14. NHS National Institute for Health and Clinical Excellence Venous thromboembolism: reducing the risk (CG92)—Quick Reference Guide, Implementation Tools, and Resources. http://www.nice.org.uk/guidance/CG92. Accessed March 4, 2014.
  15. AHRQ National Guidelines ClearinghouseTM—Hospital Acquired Conditions. http://www.guideline.gov/resources/hospital-acquired-conditions.aspx. Accessed March 4, 2014.
  16. Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: Chest 2012 Feb;141(2 suppl):53S-70S.
  17. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-1302.

Chapter 4

  1. Maynard G, Jenkins IH, Merli GJ. Venous thromboembolism prevention guidelines for medical inpatients: mind the (implementation) gap. J Hosp Med 2013,8(10):582-8.
  2. Huang W, Anderson FA, Spencer FA, et al. Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis 2013;35:67-80.
  3. Laporte S, Mismetti P. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model. Crit Care Med 2010;38(2 suppl):S10-7
  4. Spyropoulos AC, McGinn T, Khorana AA. The use of weighted and scored risk assessment models for venous thromboembolism. Thromb Haemost 2012;108(6):1072-6.
  5. O'Connor C, Adhikari N, DeCaire K, et al. Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes. J Hosp Med 2009;4(2):81-89.
  6. Maynard G. Medical admission order sets to improve deep vein thrombosis prevention: a model for others or a prescription for mediocrity? J Hosp Med 2009;4(2):77-80.
  7. Monreal M, Kakkar A, Caprini J, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004;2:1892-8.
  8. Tapson V, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007;132(3):936-45.
  9. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-94.
  10. Bergmann JF, Cohen AT, Tapson VF, et al.; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost 2010 Apr;103(4):736-48. Epub 2010 Feb 2.
  11. Michota FA. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. JGIM 2007;22(12):1762-70.
  12. Crowther MA. Medical prophylaxis: the value of an "opt in" policy. J Thromb Thrombolysis 2013;35:368-70.
  13. Qaseem A, Chou R, Humphrey LL, et al. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;Nov 1;155(9):625-32.
  14. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Chest 2012 Feb;141(2 suppl):e195S-e226S.
  15. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. Chest 2008 Jun;133(6 suppl):381S-453S.
  16. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 Feb;141(2 suppl):7S-47S.
  17. Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. Rockville MD: Agency for Healthcare Research and Quality; August 2008. AHRQ Publication No. 08-0075. Available at http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/vtguide/vtguide.pdf.
  18. Maynard G, Stein J. Preventing hospital-acquired venous-thromboembolism: a guide for effective quality improvement.v3.3. 2008. Available at http://www.hospitalmedicine.org/Web/Quality_Innovation/Implementation_Toolkits/Venous_Thromboembolism/Web/Quality___Innovation/Implementation_Toolkit/Venous/Overview.aspx. Accessed May 11,  2016.
  19. Maynard G, Morris T, Jenkins I, et al. Optimizing prevention of hospital acquired venous thromboembolism: prospective validation of a VTE risk assessment model. J Hosp Med 2010 Jan:5(1):10-18.
  20. Jenkins I, Helmons PJ, Martin-Armstrong LM, et al. High rates of venous thromboembolism prophylaxis did not increase the incidence of heparin-induced thrombocytopenia. Jt Comm J Qual Patient Saf 2011 Apr;37(4):163-9.
  21. Mitchell JD, Collen JF, Petteys S, et al. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients. J Thromb Haemost 2012;10:236-43.
  22. Maynard G, Stein J. Designing and implementing effective VTE prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  23. Maynard GA, Budnitz TL, Nickel WK, et al. Mentored implementation: building leaders and achieving results through a collaborative improvement model. 2011 John M. Eisenberg Patient Safety and Quality Award, National Level. Jt Comm J Qual Patient Saf 2012:38(7):301-10.
  24. Australian and New Zealand Working Party on the Management and Prevention of Venous Thromboembolism. Prevention of venous thromboembolism: best practice guidelines for Australia and New Zealand. 4th ed. Baulkham Hills, New South Wales, Australia: Health Education and Management Innovations;2007.
  25. Liu DS, Lee MM, Spelman T, et al. Medication chart intervention improves inpatient thromboembolism prophylaxis. Chest 2012;141:632-41.
  26. Gallagher M, Oliver K, Hurwitz M. Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital. Qual Saf Health Care 2009;18:408-12.
  27. Scaglione L, Piobbici M, Pagano E, et al. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 2005;90:678-84.
  28. Zeidan AM, Streiff MB, Lau BD, et al. Impact of a venous thromboembolism (VTE) prophylaxis "smart order set": improved compliance, fewer events. Am J Hematol 2013 Jul;88(7):545-9.
  29. Haut ER, Lau BD, Kraenzlin FS, et al. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma. Arch Surg 2012;147(10):901-7.
  30. Streiff MB, Carolan HT, Hobson DK, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.
  31. NHS National Institute for Health and Clinical Excellence. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE Clinical guideline 92. 2010. www.nice.org.uk/guidance/CG92. Accessed April 18, 2013.
  32. Arya R, Hunt B, editors. Venous thromboembolism prevention: a guide for delivering the CQUIN goal. London, UK: King's Thrombosis Centre; 2010
  33. Basey AJ, Krska J, Kennedy TD, et al. Challenges in implementing government-directed VTE guidance for medical patients: a mixed methods study. BMJ Open 2012;2(6).
  34. Roberts LN, Porter G, Barker RD, et al. Comprehensive venous thromboembolism prevention programme incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis. Chest 2013;online first doi:10:1378/chest.13-0267.
  35. Bateman AG, Sheaff R, Child S, et al. The implementation of NICE guidance on venous thromboembolism risk assessment and prophylaxis: a before-after observational study to assess the impact on patient safety across four hospitals in England. BMC Health Serv Res 2013 Jun 4;13:203.
  36. Caprini JA, Arcelus JI, Hasty JH, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991;17(suppl 3):304-12.
  37. Arcelus JI, Candocia S, Traverso CI, et al. Venous thromboembolism prophylaxis and risk assessment in medical patients. Semin Thromb Hemost 1991;17 (suppl 3):313-8.
  38. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005;51:70-8.
  39. Caprini JA. Why thromboprophylaxis fails. Vasc Dis Manage 2009;6:47-51.
  40. Bahl V, Hu H, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method based on the Caprini risk assessment model. Ann Surg 2010;251:344-50.
  41. Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg 2010;199(1 suppl):S3-10.
  42. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Chest 2012 Feb;141(2 suppl):e227S-e277S.
  43. Pannucci CJ, Barta RJ, Portschy PR, et al. Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg 2012;130(2):343-53.
  44. Abdel-Razeq HN, Hijjawi SB, Jallad SG, et al. Venous thromboembolism risk stratification in medically-ill hospitalized cancer patients. A comprehensive cancer center experience. J Thromb Thrombolysis 2010;30(3):286-93.
  45. Zhou HX, Peng LQ, Yan Y, et al. Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism. Thromb Res 2012;130(5):735-40.
  46. Bullock-Palmer RP, Weiss S, Hyman C. Innovative approaches to increase deep vein thrombosis prophylaxis rate resulting in a decrease in hospital-acquired deep vein thrombosis at a tertiary-care teaching hospital. J Hosp Med 2008;3(2):148-55.
  47. Flanders SA, Greene MT, Grant P, et al. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism. A cohort study. JAMA Intern Med 2014;174(10):1577-84.
  48. Bilimoria KY, Chung J, Ju MH, et al. Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA 2013;310 (14):1482-9.
  49. Beck MJ, Haidet P, Todoric K, et al. Reliability of a point-based VTE risk assessment tool in the hands of medical residents. J Hosp Med 2011;6(4):195-201.
  50. Kucher N, Koo S, Quiroz R, et al: Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:969-77.
  51. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009;119:2196-2201.
  52. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010;8: 2450-7.
  53. Samama MM, Combe S, Conard J, et al. Risk assessment models for thromboprophylaxis of medical patients. Thrombosis Res 2012;129:127-32.
  54. Rogers SO Jr, Kilaru RK, Hosokawa P, et al. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211-21.
  55. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. Chest 2012;141:e227S˗77S.
  56. Woller SC, Stevens SM, Jones JP, et al. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med 2011;124: 947-54 e2.
  57. Spyropoulos AC, Anderson FA, FitzGerald G, et al. for the IMPROVE Investigators. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 2011;140(3):706-14.
  58. Mahan CE, Liu Y, Turpie AG, et al. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thromb Haemost 2014 Sep 29;112(4):692-9. Epub 2014 Jul 3.
  59. Rosenberg D, Eichorn A, Alarcon M, et al. External validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system. J Am Heart Assoc 2014;3:e001152.
  60. Rothberg MB, Lindenauer PK, Lahti M, et al. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 2011;6:202-9.
  61. Decousus H, Tapson VF, Bergmann JF, et al. IMPROVE Investigators. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 2011;139 (1):69-79.

Chapter 5

  1. Osheroff JA, ed. Improving outcomes with clinical decision support: an implementer's guide. 2d ed. Chicago, IL: Healthcare Information and Management Systems Society; 2012.
  2. Bates DW, Kuperman GJ, Wang S, et al. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003;10:523-30.
  3. Nolan T, Resar R, Haraden C, et al. Improving the Reliability of Health Care. IHI Innovation Series white paper. Boston: Institute for Healthcare Improvement; 2004. http://www.ihi.org/IHI/Results/WhitePapers/ImprovingtheReliabilityofHealthCare.htm. Accessed June 5, 2013.
  4. Maynard G, Stein J. Designing and implementing effective vte prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  5. Pronovost P, Berenholz S, Needham D. Translating evidence into practice: a model for large scale knowledge translation. BMJ 2008;337:a1714.
  6. Zeidan AM, Streiff MB, Lau BD, et al. Impact of a venous thromboembolism (VTE) prophylaxis "smart order set": improved compliance, fewer events. Am J Hematol 2013 Jul;88(7):545-9.
  7. Streiff MB, Carolan HT, Hobson DK, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.
  8. Haut ER, Lau BD, Kraenzlin FS, et al. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma. Arch Surg 2012;147(10):901-7.

Chapter 6

  1. The Joint Commission Venous Thromboembolism Performance Measures. http://www.jointcommission.org/venous_thromboembolism Accessed August 24, 2013.
  2. Medicare Quality Improvement Committee. SCIP Project Information. Available from AHRQ National Quality Measures ClearinghouseTM. http://www.qualitymeasures.ahrq.gov/content.aspx?id=35538&search=scip.Accessed August 24, 2013.
  3. National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism: Policy, Preferred Practices, and Initial Performance Measures. http://www.qualityforum.org/Publications/2006/12/National_Voluntary_Consensus_Standards_for_Prevention_and_Care_of_Venous_Thromboembolism__Policy,_Preferred_Practices,_and_Initial_Performance_Measures.aspx. Accessed June 14, 2012.
  4. Meaningful use criteria for electronic health records. http://www.healthit.gov/policy-researchers-implementers/meaningful-use. Accessed August 24, 2013.
  5. Maynard G, Stein J. Designing and implementing effective vte prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  6. Maynard GA, Budnitz TL, Nickel WK, et al. Mentored implementation: building leaders and achieving results through a collaborative improvement model. 2011 John M. Eisenberg Patient Safety and Quality Award, National Level. Jt Comm J Qual Patient Saf 2012:38(7):301-10.
  7. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. Chest 2008 Jun;133(6 suppl):381S-453S.
  8. AHRQ PSI Indicators Overview and References. http://www.qualityindicators.ahrq.gov/Modules/psi_resources.aspx.Accessed Sep 16, 2015.
  9. Khanna RR, Kim SB, Jenkins I, et al. Predictive Value of the POA indicator for hospital-acquired venous thromboembolism. Med Care 2015 Apr;53(4):e31-6.
  10. Sadeghi B, Romano P, Maynard G, et al. Improving coding of postoperative deep vein thrombosis and pulmonary embolism in administrative data (AHRQ Patient Safety Indicator 12) after introduction of new ICD-9-CM diagnosis codes. Med Care 2015 May;53(5):e37-40.
  11. Rosen AK, Itani KM, Cevasco M, et al. Validating the patient safety indicators in the Veterans Health Administration: do they accurately identify true safety events? Med Care 2012;50:74-85.
  12. Henderson KE, Recktenwald A, Reichley RM, et al. Clinical validation of the AHRQ postoperative venous thromboembolism patient safety indicator. Jt Comm J Qual Patient Saf 2009;35:370-6.
  13. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 Feb;141(2 suppl):7S-47S.
  14. Qaseem A, Chou R, Humphrey LL, et alP. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011;Nov 1;155(9):625-32.
  15. Bilimoria KY, Chung J, Ju MH, et al. Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA 2013 Oct 9;310(14):1482-9.
  16. Haut ER, Noll K, Efron DT, et al. Can increased incidence of deep vein thrombosis (DVT) be used as a marker of quality of care in the absence of standardized screening? The potential effect of surveillance bias on reported DVT rates after trauma. J Trauma 2007;63(5):1132-5.
  17. Pierce CA, Haut ER, Kardooni S, et al. Surveillance bias and deep vein thrombosis in the National Trauma Data Bank: the more we look, the more we find. J Trauma 2008;64(4):932-7.
  18. Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA 2011;305(23):2462-3.
  19. Maynard G, Morris T, Jenkins I, et al. Optimizing prevention of hospital acquired venous thromboembolism: prospective validation of a VTE risk assessment model. J Hosp Med 2010 Jan:5(1):10-18.
  20. Jha AK, Kuperman GJ, Teich JM, et al. Development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-14.
  21. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care 2003;12:194-200.

Chapter 7

  1. Maynard G, Stein J. Designing and implementing effective vte prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  2. Kahn SR, Morrison DR, Cohen JM, et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism (Review). Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD008201.
  3. Streiff BM, Carolan HT, Hobson DV, et al. Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative. BMJ 2012;344:e3935.
  4. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005;241(3):397-415.
  5. Mahan CE, Spyropoulos AC. Venous thromboembolism prevention: A systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract 2010;38(1):97-108.
  6. Michota F. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process. J Gen Intern Med 2007;22(12):1762-70.
  7. Kakkar AK, Davidson BL, Haas SK. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004;2:221-7.
  8. Gawande, A. The checklist manifesto: how to get things right. New York, NY: Metropolitan Books; 2009.
  9. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005 Mar 10;352(10):969-77.
  10. Mosen D, Elliott CG, Egger MJ, et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 2004;125:1635-41.
  11. Piazza G, Rosenbaum EJ, Pendergast W, et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009;119:2196-2201.
  12. Timmons S, O'Callaghan C, O'Connor M, et al. Audit guided action can improve the compliance with thromboembolic prophylaxis prescribing to hospitalized, acutely ill older adults. J Thromb Haemost 2005;3:2112-3.
  13. Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am J Surg 1992:164(3):265-8.
  14. Li F, Walker K, McInes E, et al. Testing the effect of a targeted intervention on nurses' compliance with "best practice" mechanical venous thromboembolism prevention. J Vasc Nurs 2010;28:92-96.
  15. Elpern E, Killeen K, Patel G, et al. The application of intermittent pneumatic compression devices: an observational study found frequent errors in the application of these mechanical devices in ICUs. Am J Nurs 2013;113(4):30-36.
  16. Maynard G, Stein J. Designing and implementing effective vte prevention protocols: lessons from collaboratives. J Thromb Thrombolysis 2010 Feb:29(2):159-66.
  17. Maynard GA, Budnitz TL, Nickel WK, et al. Mentored implementation: building leaders and achieving results through a collaborative improvement model. 2011 John M. Eisenberg Patient Safety and Quality Award, National Level. Jt Comm J Qual Patient Saf 2012:38(7):301-10.
  18. Elder S, Hobson DB, Rand CS, et al. Hidden barriers to delivery of pharmacological venous thromboembolism prophylaxis: the role of nursing beliefs and practices. J Patient Saf 2014 Mar 27. [Epub ahead of print]
  19. Piazza G, Nguyen TN, Morrison R, et al. Patient education program for venous thromboembolism prevention in hospitalized patients. Am J Med 2012 Mar;125(3):258-64.
  20. Shermock KM, Lau BD, Haut ER, et al. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies. PLoS ONE 2013;8(6):e66311.
  21. Fanikos J, Stevens LA, Labreche M, et al. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med 2010:123(6): 536-41.
  22. Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost 2012;108:1097-1108.
  23. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010;138(4):803-10.
  24. Aw A, Carrier M, Koczerginski J, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res 2012:130(3):323-6.
  25. Marnejon T, Angelo D, Abu Abdou A, et al. Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J Vasc Access 2012;13(2):231-8.
  26. Brown CJ, Williams BR, Woodby LL, et al. Barriers to mobility during hospitalization from the perspectives of older patients and their nurses and physicians. J Hosp Med 2007:2(5):305-13.
  27. McCusker J, Kakuma R, Abrahamowicz M. Predictors of functional decline in hospitalized elderly patients: a systematic review. J Gerontol Med Sci 2002;57A:M569-M577.
  28. Sager MA, Franke T, Inouye SK, et al. Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med. 1996;156:645-52.
  29. Sadeghi B, Romano PS, Maynard G, et al. Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case control study. J Hosp Med 2012:7(9):665-71.
  30. Allen C, Glasziou P, DelMar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999;354:1229-33.
  31. Cameron ID, Lyle DM, Quine S. Cost effectiveness of accelerated rehabilitation after proximal femoral fracture. J Clin Epidemiol 1994;47:1307-13.
  32. Munin MC, Rudy TE, Glynn NW, et al. Early inpatient rehabilitation after elective hip and knee arthroplasty. JAMA 1998;279:847-52.
  33. Kamel HK, Iqbal MA, Mogallapu R, et al. Time to ambulation after hip fracture surgery: relation to hospitalization outcomes. J Gerontol. 2003;58A:1042-5.
  34. Pohlman M, Schweickert W, Pohlman A, et. al. Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med 2010;38 (11):2089-94.
  35. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373(9678):1874-82.
  36. Vasilevskis EE, Ely EW, Speroff T, et al. Reducing iatrogenic risks: ICU acquired delirium and weakness—crossing the quality chasm. Chest 2010;138(5):1224-33.
  37. Bailey P, Thomsen GE, Spuhler VJ, et al. Early activity is feasible and safe in respiratory failure patients. Crit Care Med 2007:35(1):139-45.
  38. Timmerman RA. A mobility protocol for critically ill adults. Dim Crit Care Nurs 2007;26(5):175-9.
  39. Maynard G, Morris T, Jenkins I, et al. Optimizing prevention of hospital acquired venous thromboembolism: prospective validation of a VTE risk assessment model. J Hosp Med 2010:5(1):10-18.
  40. Stein J, Chernetsky Tejedor S, Shabbir H, et al. Situational awareness improves prevalence of vte prophylaxis on multiple nursing units. J Hosp Med 2008;3(S1):41.

Next Page
Return to Contents

Page last reviewed May 2016
Page originally created August 2008
Internet Citation: References. Content last reviewed May 2016. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/vtguide/vtguideref.html